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TREATMENT OF HYPERТENSIVE DISEASE WIТH GERMELON 
AI. Stanchev, EI. Slavova, lv. Tso11cl1ev ancl J. Vasilev 
Altlюagl1 tl1e patl1ogeпesis апd tl1e c\iпical pictuгe are so fаг \vell 
st11ctieci, l1�·1perteпsi\ le disease still preseпts some !I1,er;,,peLt!ic difficulties. 
П1е alkaloids о[ \raгioLts species of l1ellebore l1ave Ьееп appli,ed siпce 
lоп�- iп tl1e tгeat111eпt of t\1is ail111eпt (Veгatrum \riride, Veratпtlll ali)Lllll, 
\'егаtп1111 sabactille) ( 1,2). Prepaгatioпs used so far exl1ibited t\1e dis­
act\ laпlage tl1at t\1e effecti\'e tli,era1peutic close \Vas qL1ite close to tl1e 
(ох ic опе. 
Receпtly ап alka,loict co111plex \\1itl1 lo\ver toxicity апd а 111arkecl l1ypo­
le11si\1e efiect (3, 4) \vas isolatecl fгom \/eгar!Ltt11 lol)eliaпш11 (3) апсl of­
I·eгecl for tl1e tгеаtп1еп( of l1\rpert.eпsive clisease. Tl11s alkaloicl co111plex 
\\'3S applied Liпder tl1e пате of Germeloп iп tl1e fоггп ol' 0,2 111g taЫets 
fог tl1e tгeatmeпt of l1y,perteпsive disease at tl1e C..,l1air of Pгoperle11tics 
of lпtегпаl Mediciпe at tl1e Higl1er Medical Iпstit,ute iп Vагпа. 
Clinical observations. Thirty five patieпts \Vere tг-eatecl, - 30 femal·es 
ancl 5 males, aged from 30 to 50 у.еагs - 15 аг,d frot11 51 to 70 years -
20. DL1ratioп о[ the clisordeг amouпterl to l,ess tl1a1, 1 уеаг iп 6 patients; 
from I to 5 у,еагs - in 14, from 6 to 10 years - iп 10 anrl abo\ re 10 
уеагs - in 5 patients. Accoгding to tl1e stage апd tl1e pl1ase о[ tl1e ctis­
ease tl1e .patients may Ье grouped as follows: 1 stage pl1ase В - 1 pa­
tieпt; 11 stage pl1ase А - 4; stage 11 pl1ase В - 21; stage I I I pl1ase А -
8; апd stage 111 phase В - 1 patieпt. Th,e follo\\1iпg bloorl pressLtre read­
iпgs (systolic Ыооd pгessure) \vere r.ecorded from 150 to 160 111111 - iп 
4 patieпts; [гоm 161 to 170 mI11 - iп 4; from 171 to 180 111111 - iп 6; from 
181 to 190 n1m - iп 3; from 191 to 200 mm - О апd over 200 m.п1 - iп 
18 patieпts. Diastolic Ыооd pressure: from 80 to_ 90 mm - 1 pati-ent; 
from 91 to 100 mm - 7; fгom 101 to 110 mm - 5; from 111 to 120 - 8; 
from 121 to 130 mm - 7; from 131 to 140 mm - 4 and over 140 mm -
145 111111 being the l1igl1est in 3 patients. According to occupation 14 аге 
l10L1sekeepers, 8 - p1en.sioners, 6 - clerks, 5 - workers and 2 - farmeгs. 
!п a,lmost all patients the marked subjectiv,e symptoms cl1aracteristic 
of hypertensive disease were preseпt: h,eadache, v,ertigo, dizziпess, tin­
nitus and occasioпally - insomnia, heart palpitation, paresthesia -etc. 
The patients were in а compensated status. Atherosc\erosis estaЫished 
in 9 patients being excluded, по symptoms of another ailment \vere pre­
sent. The objective examination of 14 -patients revealed ап exten.sion of 
the relative dullпess over tl1-e cardiac агеа - 1-2 cm to th-e l,eft; in 15 
patients theгe was а left pathologica1 type of EKG and in 4 left bundle 
branch Ыосk. The roentgenological examination in 26 patients discove­
red ап aortic configшation of th,e heart. Angiopathia hypertonica was 
present in 20 pati,ents. Proteinuria from tr:;>ce� tп 10/оо was detected in 
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2 patieпts. Сопсепtгаtiпg capacity of tl1e kidпeys after Voll1ard was 
li.mited to Ь low 1028 iп 4 patieпts апd l1yposteпuria was preseпt in 3 
patieпts. Blood uгеа iп the latter was 58, 78 a11d 98 mg %. Renal dis­
ordeгs •secondaгy to Ыооd hyperteпsio11 wer,e probalJly preseпt iп these 
cases. Blood cholest,ero,] levels examiпed i11 11 patieпts \Vere witl1i11 11or­
mal limits. The proteiпogram апd floculatioп tests displayed 110 sub­
staпtial deviatioпs from the normal. Lipidograms were поt followed up. 
Тгеаtше11t witl1 Gепnе!оп ,vas USLtally i11stituted 011 tl1e 4111 day 
after hospital addmiss·io11 in а ·state of comparati,•ely staЫ.e \'al.ues of the 
arterial Ыооd 1pressure. The iпitial close was 011е taЫet i11 th,e morпing 
and at 110011 after meals; 2-3 days later ап eveпiп.g do-se was added uпtil 
gradually а maximal daily dose of 8 tablets was reached. Treatme11t co11-
ti11ued for 20-25 days. No otl1,er !1y1pote11sive treatmeпt ,vas carried out 
dшi11g the same period. All ,patieпts were subjected to r]iet No. 10 after 
Pevz11er. Daily contгols of Ыооd pгessure were carгied out at staпdard 
co11ditioпs. The cha11g•es iп the subjective symptoms апd the objective 
fiпdi11gs a.s well as some clinical and laboratory i11dices were fOJ]lowed up. 
Out-patient observations. Ger:melon was admiпistered to seven 
patie11ts treilted at the Cli11ic алd follo-wed up as out-pati-e11ts after hos­
pital discha,rg,e. Тгеаtше11t was carгied out ,vith 2-3 tab,l,ets daily, i.e. 
'lз-'/1 of the cli11ical do;se fог а month a11d а ha,lf. During this period 
t,he patie11ts wer,e subject,ed to а t1ygieпic апd dietary regime11 at hоше 
a11d at work corгespoпdi11g to the ailmeпt, 110 other treatmeпt was ad­
mi11ist,ere,d. 
Results 
1. Patients treated at the Clinic. TQIWarids the 4-бth -day after tгeat­
me11t wa.s started а сопsidегаЫ.е atteп,uaticm of the subjective symptoms 









ache, ,1ertigo a11d i11somnia were 
primarily a11d most markedly af­
fected, followed Ьу dizzi11ess, tiп­
nitus, par,esth,esia a11d i11cr,eased 
пervous irritability. I11 5 patie11ts 
the subjective symptoms were less 
affected. I11 3 patie11ts 110 sub-
sta11tial improverne11t was re­
corded. 
On the 4-бth day after treatme11t 
was i11stituted, th-ere also follo•�•ed 
а d,ecreas,e i11 the Ыооd pr•essur,e 
readi11gs. The hypot-e11si,r,e eff.ect 
1С 
Diagт. 
15 days of Germelo11 was exte11ded botl1 
over th,e systol ic a11d diastolic 
Ыооd pressure, but more clearly 
over the former 011е. Iп Diagram 1 
the m-ean va1l,ues аге show11 of the systolic a11d diasto.lic Ыооd pressure i11 
35 ,patie11ts tr,eated w,ith 9ermelo11 towarrls_ the I
, Х, XV day after t,reat­
me11t. Towards the fift,ee11th day the systol1c Ыооd ,pressur.e was redLtced 
3 Tгcall)lpпt of· l1yperl�пsl�,e disease "'ill1. Ger111eJoп 
Ь,· аЬ{)нt 17,6% апd the diastolic - Ьу а,Ьщ1t 11;8% as сотраге(;[ ,vitl1 \l1e 
со·ггеsропdiпg iпitia1\ valш:s. '' 
. Тl1_iгty t,vo patieпts \\'еге 1·аvо�1гаЫу iпflL1encecl 
1
Ьу lгealllleпt \\1 ill1 
Gerllleloп: stage I p\1ase В - 1 pat1-ent; stage 1! ,р\1цsе А - 4; stag.e IIJ 
phase В - 19; ,stag,e 11! pl1ase А - 7, апd stag·e ТII p\1a:ie В - 1,. №, 
tl1erapeutic effect ,,,а г-есолdесl iп· 3 pati1e11ts - t,,10 of tl1eп1 i11 stage·�I! 
pl1ase В апс\ опе iп stage 111 pl1ase А. '- · · · 
Т11с follo\,,iпg ol)seг,·ations illL1stгate lllore cleaгly tl1e effecl of Ge1-
melon: 
No. l. A.K.S., aged 37, с. 11. 10 150/1962. А ll1ree уеаг d11ratioп of tl1e disoгdei-
1vitl1 l1eadacl1e, occipital pressure, vertigo, dizziness, l1eart . palpitation. Thc cardiac bor­
der \\'as extendecl Ь11 about 1 cm to tl1e left: а short systolic- m11rm11r ,..,a·s ·audiЬ!e ovei­
ll1e mitral ,,а[уе; tlie secoпd aortic sound ,vas accentuated; EKG - irdiifer�пt 1уре, 
sinus rl1ytl1m, а decrease of ST,,? апd isoelectric Т? ; roeпtgenologically .. - aortic coп­
iigшatioп. ,lv\arked l1ypertensi1•e angiopatl,y of tl1e retina, Coпceпtrating capacity aftcr 
\loll1aгdl - up to 1025, Ыооd urea - 78 mg %. The patieпt 1vas classified as beloпging 
lo stage 111 phase А. Blood pressure оп addmission ,vas 240/130 mm. To1vards the 11th 
day it 1vas 190/105 апd оп the 20th day - 150/95 mm. Tl1e subjectiye symptoms "'�Г� 
i111proyed early - 11,itl,in tl1e first fe1v days of treatment. Abo11t lhe 10th day after 
treatment 1vas discoпtinued Ыооd pressure 11gaiп began to rise. No 011t-patient lreat­
ment ,vas carried out. 
No. 2. H.N.M., aged 47, с. 11. 9025/1962, l1ypertensive dlsease of 5 years dura­
tion. Complains of compression and pains iп the occipital region, vertigo, tiлnitus, (!iz­
ziness and heart palpitation. The he-art is dilated Ьу about I cm lo tl,e left, tl,e �econd 
aortic souпd is accentu�ted. EKG - left type, l01v Т ?• aortic configuration or the ]1eart, 
tl1e l01ver area of the retrocardiac space being filled in. Tortous retinal ,,essels ·-апd 
small l1aemorrhages. Concentratiпg capacity after Voll1ardl - up to 1028, Ыооd urea -
19 mg %. The patient belonged to stage 11 phase В. Blood pressure оп admission 
205/110 mm dropped lo,vard the 6th day after treatmeпt to 160/90 mm апd 1vas ma(п­
tained а! this level till tl1e епd of treatment. Т11е subjective symptoms were attenнated 
abo11t tl1e 4(11 day after treatment was started. To,vards tl1e 10!11 day after treatment "'as 
disconlinued tl,e Ыооd pressure ll'as elevated again. No out-patieпt treatmeпt 11,as pre-
scribed. - -
Gerll elon was geп-erally webl toleгated Ьу t\1,e pati,enbs. No com,plica­
tions w,ere record-ed. No changes in the гаtе апd d-epth of -breathing; heart 
rhythm, EKG, defecatioп, urinary findiпgs апd Ыооd pictшe wеге est�q­
lished. No pathologic deviations occurr,ed iп the prot•einogram, flocc;u(a­
tioл tests, Ыооd cholesterol level, Ыооd urea etc. Towards the third day 
following tгeatment th-e ,patieпts coll p·lained of пausea апd slight epi­
gastric pains, which coпtiпu-ed fог 2-3 days апd subsided �1it\10ut di,scoп­
tiпuiпg the treatment. !п опе pati•eпt iпs.pissation of sali,,a апd dryпess 
of the ll outh was observed, while iп anotl1er опе cardiac acti,,ity dropped 
frolll 96 to 56 beats рег minute. . . ... .· 
11. Patients treated in the ward and in · the out;p'a.tiebl service 
Iп 6 out of the 7 patieпts treated w.ith 2-3 tablets Germelon dai,ly, 
after they wеге discharged from l1ospital iп ап iшproved condition, а 
favouraЫe effect was record-ed as regards tl1e .subjective symptoms: 
headacl1e, vertigo, precordial discomfoгt etc. Blood pressure remained 
wit·hin the va!L1es recorded Ьу the time of h9s•pita\ -dts.charge. Теп, days 
after tгeatlllent was discoпtiпued Ы.ооd ргеssше опее again i11cre;:i,ped. 
It was broL1gl1t uпder сопtго! wit\1 resumptioo .of treatment. Т.wо of tl1e 
six patieпts who displayed these results wеге iп ',,tag,e. 11 ,p\1ase А ;шd 
4 iп stage 11 phase В. The patieпt unaffected Ьу treatцient suffered fхщп 
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No. 3. B.V.P., aged 43, с. 11. No. 6646/1962. With hypertensi,,e disease of 2 
years dшation and Ыооd pressure 240/115 mm ll1e patient ,vas treated ,vith 8 taЫets 
Germelon daily. PrematL1re discharge from hospital foltowed on tl,e 8th day ,vith Ыооd 
pressure amounting to 145/85 mm. Out-patient treatment contiпued after the following 
schedнle: 1 day 4 taЫets, 11 day - 5 taЫets, 111 day - 6 taЫets, follo,ved Ьу three 
taЫets daily for 50 days. Blood pressurc, measured every 5-10 days varied belween 
145/85 mm and 170/95 mm. Discontinuation of treatment for about 10 days ,vas fol-
1011,ed Ьу repeated elevation of Ыооd pre�sure. 
Conclusions 
1. The preparatioл Germelon administered in а dose of 8 taЫet-s daily 
under hospital and out-.patient conditions exerts а hypotensive effect. 
2. Most ap:propriat,e for Germelon treatment ар.реаг to Ь·е patients 
suffering from hy,perteпs·ive disease, stage I ,pha·se В, stage II phase А 
and phase В and partly those o,f ,stage I I I phase А, i-e. the milder and 
earli•er forms of the disorder. 
3. After the maximal eff,ect is oьtain-ed under cli11ical conditions а 
maintenance o,ut-patient dose ap1pear-s to Ь,е 1/2 to '/з of the clinical dose. 
About 10 days after treatment is discontiПJued Ыооd pres.sure re-sumes 
higher values which аге J,ow,ered when th.erapy is started опее again. 
4. Almost simultan-eous,\y with the hypoten.si,1e effect alleviation of 
the subj:ective symptom,s characteri.stic of the ailment is estaЫished. This 
is ob&erv,ed on the 4-бth day following Germe,lon treatment. 
5. The drug is wel_l tol,erated. Si.de effect.s аге infrequent and insigni­
ficant. No complications ar,e observed-
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РЕЗЮМЕ 
Сообщаются результаты клинического испытания нового болгарского 
препарата „Гермелон", примененного при лечении 35 больных, сре­
ди которых 30 женщин и 5 мужчин. Дается схеыа лечения препаратом и 
у•штыв,ается, что он имеет максимальную эффективность в !-ой стадии 
фазе Б и во 11-ой стадии фазах А и Б гипертонической болезни. Подчер­
кивается хорошая перен-осимосп, препарата, дающего только незначн­
тельные побочные явления. 
